| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00578903 NCT00598221 Details | 2016-04-22 Interventional | 2 | 22 | Alemtuzumab Cyclophosphamid… Methotrexate Tacrolimus Anemia Anemia, Aplasti… Aplastic Anemia | - - | |||
| NCT02598687 Details | 2016-04-21 Interventional | 1 | 0 | Carboplatin Paclitaxel Esophageal Neop… Esophageal Canc… | 2 Phase 3 trials didn't meet their primary endpoint, so further development and testing of
TH-302 is uncertain - | |||
| NCT02349828 Details | 2016-04-21 Interventional | 2/3 | 0 | Acyclovir Herpes Simplex | PI decided to stop due to divisional reorganization. No pts enrolled. - | |||
| NCT00973193 Details | 2016-04-20 Interventional | 2 | 20 | Panitumumab Rectal Neoplasm… Rectal Cancer | The intermediate analyses did not allowed to continue the clinical study. - | |||
| NCT00523120 Details | 2016-04-20 Interventional | 2 | 20 | Diclofenac Otitis Otitis Externa | - - | |||
| NCT01762657 Details | 2016-04-19 Interventional | 3 | 0 | Cyclosporine Cyclosporins Dexlansoprazole Lansoprazole Diabetes Mellit… Diabetes Mellit… Type 1 Diabetes | Study stopped prior to Patient Enrollment - | |||
| NCT01563614 Details | 2016-04-19 Interventional | 1 | 1 | Cytarabine Lomustine Melanoma Meningeal Carci… Neoplasm Metast… Leptomeningeal … | No patients can be recruited for this trial anymore due to other therapeutical approaches that
became available. - | |||
| NCT01045876 Details | 2016-04-19 Interventional | 4 | 0 | Dexamethasone Adrenal Insuffi… | Lack of resources - | |||
| NCT00510289 Details | 2016-04-19 Interventional | 2 | 19 | Sorafenib Leukemia, Myelo… Myelodysplastic… Preleukemia Syndrome | Early closure of study due to poor response The limitations of our study include the small sample size, the poor toxicity profile and the lack of response. | |||
| NCT00287326 Details | 2016-04-19 Interventional | 3 | - | Bupivacaine Clonidine Morphine Pain | terminated by PI - | |||
| NCT01955629 2013-000858-22 Details | 2016-04-18 Interventional | 1/2 | 4 | Aflibercept Capecitabine Oxaliplatin Colorectal Neop… Colorectal Canc… | The study enrollment was prematurely halted due to safety reasons. The study enrollment was prematurely halted due to safety reasons. | |||
| NCT01762644 2015-000105-39 Details | 2016-04-18 Interventional | 3 | 0 | Cyclosporine Cyclosporins Omeprazole Diabetes Mellit… Diabetes Mellit… Type 1 Diabetes | This study was withdrawn prior to enrollment. - | |||
| NCT02190526 Details | 2016-04-15 Interventional | 4 | 0 | Amitriptyline Mesalamine Diarrhea Irritable Bowel… Syndrome Diarrhea- Predo… Quality of Life | Study stopped due to lack of volunteer patients. - | |||
| NCT01578343 Details | 2016-04-15 Interventional | 2 | 20 | BB 1101 Dexamethasone Dexamethasone a… Fludarabine Fludarabine pho… Mitoxantrone Vorinostat Lymphoma Lymphoma, Mantl… Mantle Cell Lym… | we collected data of a total of 19 patients for an interim analysis. but there are less than 7
responses out of the initial 19 patients. - | |||
| NCT01489046 2011-003329-89 Details | 2016-04-15 Interventional | 2 | 297 | Efavirenz Lamivudine Tenofovir Infections HIV-1 Infection | - - | |||
| NCT02479178 Details | 2016-04-14 Interventional | 2 | 73 | Docetaxel Carcinoma Carcinoma, Squa… Carcinoma, Tran… Cholangiocarcin… Squamous Cell C… Uterine Cervica… Cervical Cancer Urothelial Carc… | - - | |||
| NCT01765803 Details | 2016-04-14 Interventional | 1 | 6 | Thioridazine Healthy Subject… | Primary objective not met after planned interim analysis - | |||
| NCT02428218 2014-005624-98 Details | 2016-04-13 Interventional | 3 | 0 | Dimethyl Fumara… Multiple Sclero… Multiple Sclero… Sclerosis Relapsing Forms… Relapsing-Remit… | Feasibility - | |||
| NCT01670071 Details | 2016-04-13 Interventional | 4 | 17 | Paliperidone Pa… Risperidone Schizophrenia | The study was terminated due to insufficient sample size and protocol compliance issue. - | |||
| NCT01390545 2010-022378-15 Details | 2016-04-13 Interventional | 2 | - | Veltuzumab Arthritis Arthritis, Rheu… Rheumatoid Arth… | Trial re-design; no safety issues identified - |